What types of information should I have ready when searching for clinical trials that match my diagnosis
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I'll help you understand what information you'll need to effectively search for clinical trials. Here's what you should have ready, based on trusted medical sources:
According to the National Cancer Institute (NCI), these are the essential details you should gather:
- Basic Medical Information:
- Exact type and subtype of cancer
- Stage of cancer
- Location of cancer and if it has spread
- Previous treatments received
- Current medications
- Other medical conditions you have
- Personal Information:
- Age
- Gender
- Performance status (how well you can perform daily activities)
- Travel limitations for trial participation
The American Society of Clinical Oncology (ASCO) additionally recommends having:
- Recent lab test results
- Genetic testing results (if performed)
- Biomarker testing results
- Complete treatment history, including dates
- List of any allergies
- Detailed medical history
The National Comprehensive Cancer Network (NCCN) Guidelines emphasize knowing:
- Your exact diagnosis date
- Specific molecular/genetic markers of your cancer
- Any complications from previous treatments
- Your ability to comply with study requirements
- Insurance coverage details
Always remember that your healthcare team is the best resource for helping you gather this information accurately. They can help ensure you have the most current and relevant details for trial matching.
These details will help match you with trials for which you're potentially eligible, saving time in the screening process.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with clinical trials for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ